Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers

  1. Hutchinson, K.E.
  2. Chen, J.W.
  3. Savage, H.M.
  4. Stout, T.J.
  5. Schimmoller, F.
  6. Cortés, J.
  7. Dent, S.
  8. Harbeck, N.
  9. Jacot, W.
  10. Krop, I.
  11. Trabucco, S.E.
  12. Sivakumar, S.
  13. Sokol, E.S.
  14. Wilson, T.R.
Journal:
Genome Medicine

ISSN: 1756-994X

Year of publication: 2023

Volume: 15

Issue: 1

Type: Article

DOI: 10.1186/S13073-023-01181-8 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus